REGENXBIO Inc.
DE ˙ DB ˙ US75901B1070
6,20 € ↓ -0,10 (-1,59%)
2026-06-02
CENA AKCJI
SecurityDE:RB0 / REGENXBIO Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership393,640 shares
Latest Disclosed Value $ 3,298,703
Northern Trust Corp reports 5.34% increase in ownership of RB0 / REGENXBIO Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 393,640 shares of REGENXBIO Inc. (DE:RB0) valued at $2,716,116 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 373,689 shares of REGENXBIO Inc.. This represents a change in shares of 5.34% during the quarter. The current value of the position is $2,440,568 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F REGENXBIO COM 75901B107 393,640 19,951 5.34 3,299 -38.71 0.0004
2026-02-17 2025-12-31 13F REGENXBIO COM 75901B107 373,689 -27,321 -6.81 5,381 39.08 0.0007
2025-11-14 2025-09-30 13F REGENXBIO COM 75901B107 401,010 930 0.23 3,870 17.81 0.0005
2025-08-13 2025-06-30 13F REGENXBIO COM 75901B107 400,080 -7,040 -1.73 3,285 12.85 0.0005
2025-05-13 2025-03-31 13F REGENXBIO COM 75901B107 407,120 -58,141 -12.50 2,911 -19.08 0.0004
2025-02-14 2024-12-31 13F REGENXBIO COM 75901B107 465,261 -22,726 -4.66 3,596 -29.74 0.0005
2024-11-13 2024-09-30 13F REGENXBIO COM 75901B107 487,987 55,737 12.89 5,119 1.21 0.0008
2024-08-14 2024-06-30 13F REGENXBIO COM 75901B107 432,250 465 0.11 5,057 -44.41 0.0009
2024-05-14 2024-03-31 13F REGENXBIO COM 75901B107 431,785 -14,988 -3.35 9,098 13.44 0.0016
2024-02-13 2023-12-31 13F REGENXBIO COM 75901B107 446,773 16,738 3.89 8,020 13.29 0.0015
2023-11-13 2023-09-30 13F REGENXBIO COM 75901B107 430,035 15,356 3.70 7,078 -14.61 0.0014
2023-08-11 2023-06-30 13F REGENXBIO COM 75901B107 414,679 4,281 1.04 8,289 6.82 0.0016
2023-05-15 2023-03-31 13F REGENXBIO COM 75901B107 410,398 -18,551 -4.32 7,761 -20.23 0.0015
2023-02-13 2022-12-31 13F REGENXBIO COM 75901B107 428,949 -59,225 -12.13 9,729 -24.61 0.0020
2022-11-14 2022-09-30 13F REGENXBIO COM 75901B107 488,174 65,060 15.38 12,903 23.46 0.0029
2022-08-12 2022-06-30 13F REGENXBIO COM 75901B107 423,114 8,099 1.95 10,451 -24.13 0.0022
2022-05-13 2022-03-31 13F REGENXBIO COM 75901B107 415,015 -11,387 -2.67 13,774 -1.22 0.0024
2022-02-08 2021-12-31 13F REGENXBIO COM 75901B107 426,402 -58,316 -12.03 13,944 -31.37 0.0023
2021-11-15 2021-09-30 13F REGENXBIO COM 75901B107 484,718 6,458 1.35 20,319 9.36 0.0036
2021-08-13 2021-06-30 13F REGENXBIO COM 75901B107 478,260 39,515 9.01 18,580 24.15 0.0033
2021-05-12 2021-03-31 13F REGENXBIO COM 75901B107 438,745 48,013 12.29 14,966 -15.56 0.0028
2021-02-11 2020-12-31 13F REGENXBIO COM 75901B107 390,732 -8,208 -2.06 17,723 61.43 0.0035
2020-11-16 2020-09-30 13F REGENXBIO COM 75901B107 398,940 -30,354 -7.07 10,979 -30.56 0.0024
2020-08-14 2020-06-30 13F REGENXBIO COM 75901B107 429,294 18,929 4.61 15,811 18.99 0.0037
2020-05-14 2020-03-31 13F REGENXBIO COM 75901B107 410,365 3,219 0.79 13,288 -20.34 0.0038
2020-02-14 2019-12-31 13F REGENXBIO COM 75901B107 407,146 -23,069 -5.36 16,681 8.92 0.0037
2019-11-13 2019-09-30 13F REGENXBIO COM 75901B107 430,215 4,110 0.96 15,315 -30.03 0.0037
2019-08-13 2019-06-30 13F REGENXBIO COM 75901B107 426,105 7,922 1.89 21,889 -8.67 0.0052
2019-05-13 2019-03-31 13F REGENXBIO COM 75901B107 418,183 5,195 1.26 23,966 38.33 0.0059
2019-02-12 2018-12-31 13F REGENXBIO COM 75901B107 412,988 3,099 0.76 17,325 -44.02 0.0049
2018-11-14 2018-09-30 13F REGENXBIO COM 75901B107 409,889 50,849 14.16 30,946 20.12 0.0076
2018-09-18 2018-06-30 13F/A-1 REGENXBIO COM 75901B107 359,040 62,849 21.22 25,762 191.39 0.0065
2018-08-14 2018-06-30 13F REGENXBIO COM 75901B107 360,772 64,581 25,886
2018-05-09 2018-03-31 13F REGENXBIO COM 75901B107 296,191 81 0.03 8,841 -10.21 0.0023
2018-02-14 2017-12-31 13F REGENXBIO COM 75901B107 296,110 -19,295 -6.12 9,846 -5.26 0.0025
2017-11-13 2017-09-30 13F REGENXBIO COM 75901B107 315,405 11,221 3.69 10,393 72.99 0.0027
2017-08-11 2017-06-30 13F REGENXBIO COM 75901B107 304,184 88,202 40.84 6,008 44.11 0.0017
2017-05-12 2017-03-31 13F REGENXBIO COM 75901B107 215,982 913 0.42 4,169 4.51 0.0012
2017-02-13 2016-12-31 13F REGENXBIO COM 75901B107 215,069 15,799 7.93 3,989 42.92 0.0012
2016-11-09 2016-09-30 13F REGENXBIO COM 75901B107 199,270 22,469 12.71 2,791 97.24 0.0009
2016-08-12 2016-06-30 13F REGENXBIO COM 75901B107 176,801 107,775 156.14 1,415 89.93 0.0005
2016-08-19 2016-03-31 13F/A-1 REGENXBIO COM 75901B107 69,026 496 0.72 745 -34.53 0.0002
2016-05-13 2016-03-31 13F REGENXBIO COM 75901B107 69,026 745
2016-02-12 2015-12-31 13F REGENXBIO COM 75901B107 68,530 68,530 1,138 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.